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Abstract
Agonist responses and channel kinetics of native a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors
are modulated by transmembrane accessory proteins. Stargazin, the prototypical accessory protein, decreases
desensitization and increases agonist potency at AMPA receptors. Furthermore, in the presence of stargazin, the steady-
state responses of AMPA receptors show a gradual decline at higher glutamate concentrations. This ‘‘autoinactivation’’ has
been assigned to physical dissociation of the stargazin-AMPA receptor complex and suggested to serve as a protective
mechanism against overactivation. Here, we analyzed autoinactivation of GluA1–A4 AMPA receptors (all flip isoform)
expressed in the presence of stargazin. Homomeric GluA1, GluA3, and GluA4 channels showed pronounced
autoinactivation indicated by the bell-shaped steady-state dose response curves for glutamate. In contrast, homomeric
GluA2i channels did not show significant autoinactivation. The resistance of GluA2 to autoinactivation showed striking
dependence on the splice form as GluA2-flop receptors displayed clear autoinactivation. Interestingly, the resistance of
GluA2-flip containing receptors to autoinactivation was transferred onto heteromeric receptors in a dominant fashion. To
examine the relationship of autoinactivation to physical separation of stargazin from the AMPA receptor, we analyzed a
GluA4-stargazin fusion protein. Notably, the covalently linked complex and separately expressed proteins expressed a
similar level of autoinactivation. We conclude that autoinactivation is a subunit and splice form dependent property of
AMPA receptor-stargazin complexes, which involves structural rearrangements within the complex rather than any physical
dissociation.
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Introduction
Cellular localization and functional properties of a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
are strongly influenced by transmembrane AMPA receptor
regulatory proteins (TARP) (for reviews, see [1,2,3]). To date,
six homologous TARP, named as c2–5, c7, andc8, have been
identified and found to participate in the regulation of neuronal
and glial AMPA receptors [4,5,6,7,8]. Stargazin (c2), the founding
and best characterized member of TARP family, enhances AMPA
receptor function by at least two distinct mechanisms. It is a key
operator in AMPA receptor trafficking by promoting receptor
transport to cell surface and stabilization to synaptic membrane
[4,5,9]. Stargazin also enhances the ligand-gated channel function
of AMPA receptors by increasing agonist affinity, decreasing
densensitization, and by weakening polyamine block of Ca2+-
permeable AMPA receptors at depolarized potentials
[10,11,12,13,14]. Moreover, association with stargazin leads to
profound changes in agonist and antagonist pharmacology of
AMPA receptors [15,16,17,18]. Due to this profound modulation
and the near-stoichiometric association of native AMPA receptors
with stargazin and related TARP [19], the complex between
TARP and AMPA receptor has become a critical subject for
studies addressing the structure and function of AMPA receptors.
An interesting new facet of TARP modulation was revealed by
the recent demonstration that in the presence of stargazin, steady-
state glutamate responses of AMPA receptors exhibit an aberrant
decline at concentrations $ 100 mM [20]. This phenomenon,
termed autoinactivation, was linked to a time- and concentration -
dependent uncoupling of stargazin -receptor interaction, via
dissociation of the complex [20]. In the present study, we have
investigated stargazin-dependent autoinactivation in GluA1-4
AMPA receptors. We demonstrate the presence of striking
subunit- and splice variant-dependent differences in autoinactiva-
tion and present data to support the notion that autoinactivation
and physical dissociation of stargazin-AMPA receptor complex are
separate processes.
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Results
Subunit-dependent differences in autoinactivation
AMPA receptor subunits GluA1-4 were expressed together with
stargazin in transiently transfected HEK293 cells, and the
resulting homomeric channels were characterized by using whole
cell patch clamp recordings. All subunits were of the flip isoform
(GluA1-4i), and the GluA2 subunit was edited (R) at the Q/R site.
With GluA1i, GluA3i, and GluA4i, a bell-shaped relation was
observed between the steady-state current amplitudes and
glutamate concentration, indicative of the presence of autoinacti-
vation (Figure 1A,C,D). Glutamate concentration yielding the
highest steady-state current differed slightly between subunits: for
GluA1i and GluA4i, the maximal steady-state current response
was obtained at 10 mM, whereas GluA3i channels gave the highest
response at 100 mM glutamate concentration. For all three, steady-
state responses obtained at millimolar range (1–10 mM glutamate)
corresponded to 50–60% of the highest steady-state response
obtained at micromolar concentrations. In striking contrast to the
three other homomeric channels, GluA2i consistently produced
ordinary sigmoid concentration-response curves with no sign of
decline in steady-state current amplitudes at the millimolar range
(Figure 1B). Unlike the variation in the dose-response relationships
of steady-state currents, the peak current responses of all four
homomeric receptors gradually increased with increasing gluta-
mate concentration (Figure 1E), fully consistent with the suggestion
that autoinactivation represents time-dependent uncoupling of
stargazin-modulation from AMPA receptors [20]. These findings
indicate that autoinactivation of AMPA receptors is a subunit- and
splice form-dependent property: homomeric GluA1i, GluA3i, and
GluA4i channels exhibit robust autoinactivation, while GluA2i
under similar conditions shows no significant autoinactivation.
Isoform-dependent autoinactivation in GluA2 channels
The striking absence of autoinactivation in GluA2i prompted us
to characterize GluA2 channels further. When expressed alone,
without stargazin, GluA2i showed only minimal current responses
to glutamate and kainate. However, in the presence of stargazin,
GluA2i gave robust responses, comparable in amplitude to those
produced by GluA4i (Figure 2A). These findings are in agreement
with the poor channel activity of homomeric Q/R-edited GluA2
channels, and also exclude a lack of interaction with stargazin as a
(trivial) explanation for the resistance of GluA2i to autoinactiva-
tion. A previous study suggested that GluA2o receptors exhibit
autoinactivation [20], prompting us to determine whether the
discrepant behavior of GluA2i is related to the flip/flop isoform.
As shown in Figure 2B, GluA2o channels coexpressed with
stargazin exhibit robust autoinactivation, contrary to GluA2i (cf.
Figure 1B), indicating that the flip/flop exon is a key determinant
of autoinactivation in GluA2 receptors.
GluA2 subunit is a component in the majority of native AMPA
receptors. Thus, we tested whether the conspicuous absence of
autoinactivation in homomeric GluA2i channels is also manifested
in a heteromeric setting. For this purpose, glutamate responses
were registered from cells coexpressing both GluA2i and GluA1i
with stargazin. Steady-state responses recorded from these cells
rose gradually with increasing agonist concentrations and saturat-
ed at millimolar range, suggesting that autoinactivation is either
absent or strongly reduced in GluA1i/A2i channels (Figure 2C).
EC50 values determined for glutamate peak responses of GluA1i/
A2i and GluA1i were very similar and distinct from GluA2i;
GluA1i/A2i: 143 mM (95% confidence interval: 121–171 mM),
GluA1i: 165 mM (138–216 mM), GluA2i: 32.3 mM (28.2-36.6 mM)
(Figure S1). However, glutamate-triggered current responses
recorded at three holding potentials, 260 mV, 0 mV, and
+40 mV, showed strong inward rectification in GluA1i channels,
whereas the responses from GluA1i/A2i and homomeric GluA2i
channels indicated a more linear current-voltage relation
(Figure 2D). Rectification index, I(260 mV)/I(+40 mV), was
16.065.8 (n = 5) for GluA1 alone, 1.4160.17 (n= 8) for GluA2i
alone, and 1.3960.41 (n= 7) for GluAi/A2i receptors (P,0.001
for the difference between GluA1i and either GluA2i or GluA1i/
A2i). The unique functional profile of GluA1i/A2i channels
suggests that the potential contribution of any separate homomeric
GluA1i or GluA2i channel populations to the current responses,
and thus, to the apparent absence of autoinactivation observed in
GluA1i/A2i -expressing cells is minor. Therefore, the presence of
GluA2i subunit can confer substantially reduced sensitivity to
stargazin-dependent autoinactivation of heteromeric AMPA
receptors, at least in the case of GluA1i/A2i heteromers.
Autoinactivation in AMPA receptor - stargazin fusion
protein
We studied the dependence of autoinactivation on physical
dissociation of AMPA receptor and stargazin by using a covalently
bound fusion protein in which the C-terminus of GluA4i is linked
to the N-terminus of stargazin by a short linker peptide (Figure 3A).
Potentially, such a design would allow the formation of a
functional complex between stargazin (stg) and the AMPA
Figure 1. Subunit-dependent differences in stargazin-depen-
dent autoinactivation of AMPA receptors. (A–D) Steady-state
concentration-response curves of L-glutamate-triggered current re-
sponses of homomeric GluA1i (A), GluA2i (B), GluA3i (C) GluA4i (D)
channels coexpressed with stargazin. (E) Concentration-response curves
of L-glutamate-triggered peak responses of homomeric GluA1-4i
receptors. Currents were normalized to the maximal response obtained
for each channel. The points represent the mean 6 S.E.M of recordings
from 5–6 cells from a typical experiment.
doi:10.1371/journal.pone.0049282.g001
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receptor and strongly drive the binding equilibrium towards the
complex by maintaining high local concentrations of the
components. Immunoblots detecting the N-terminal Flag epitope
present in GluA4i and GluA4i-stg, and with an antibody specific
for stargazin C-terminus, revealed protein products of expected
size and the absence of any significant degradation products
(Figure 3B). The electrophysiological properties of the fusion
protein were preliminarily characterized by whole-cell patch
clamp recordings, and then, in more detail and with similar
results, by two-electrode voltage-clamp on cRNA-injected Xenopus
oocytes, a convenient system for the analysis of steady-state
responses.
First, we analyzed the I/V -relations of glutamate responses in
order to ascertain the ability of the fusion protein to reproduce the
basic functional properties of GluA4i coexpressed with stargazin.
The inward rectification of GluA4i channels expressed in the
absence of stargazin was significantly attenuated in the presence of
coexpressed stargazin in the oocytes in agreement with earlier
findings [14] (Figure 3C,D). Importantly, this attenuation of
inward rectification was reproduced by covalently linked stargazin
in an indistinguishable fashion from that observed with separately
expressed proteins. Next, we measured the concentration-depen-
dency of steady-state glutamate responses to reveal the presence or
absence of autoinactivation. Current amplitudes recorded from
oocytes expressing GluA4i alone showed a regular saturating
concentration-dependency, whereas in the presence of stargazin, a
significant decline of responses occurred as millimolar concentra-
Figure 2. Absence of autoinactivation in homomeric and
heteromeric GluA2 channels. (A) Representative current traces
from patch clamp recordings of homomeric GluA2i and GluA4i channel
responses to glutamate (10 mM) and kainate (0.7 mM) in the presence
(red traces) and in the absence (blue traces) of stargazin. (B)
Concentration-response curves of peak (open circles) and steady state
(filled circles) L-glutamate responses of homomeric GluA2o channels
coexpressed with stargazin. (C) Concentration-response curves of peak
(open circles) and steady state (filled circles) L-glutamate responses of
heteromeric GluA1i/A2i channels coexpressed with stargazin; (D)
Rectification properties of heteromeric GluA1i/GluA2i (left), homomeric
GluA1i (middle), and homomeric GluA2i (right) channels, all in the
presence of stargazin. Representative traces of glutamate-evoked
currents at holding potentials of +40 mV, 0 mV, and 260 mV are
shown. The inset shows an enlarged view of GluA1i steady-state
currents.
doi:10.1371/journal.pone.0049282.g002
Figure 3. Autoinactivation of GluA4i - stargazin complex is not
affected by covalent linkage between the proteins. (A)
Schematic structure of GluA4i, stargazin and GluA4i-stargazin fusion
protein. Amino acid sequence of the linkage between the carbox-
yterminus of GluA4 and the aminoterminus of stargazin is shown below
the cartoon. (B) Western blot of GluA4i, stargazin and GluA4i-stargazin
fusion protein detected by using anti-Flag (upper panel) and anti-
stargazin (lower panel) antibodies. Molecular size markers (in kilo-
daltons) are indicated at the right. (C–D) Current-voltage relations of
responses to L-glutamate (1 mM) in oocytes expressing the covalent
GluA4i-stargazin fusion protein (black), and GluA4i expressed alone
(blue) or in the presence of stargazin (red). (E) Concentration-response
curves of L-glutamate -triggered currents in oocytes expressing the
covalent GluA4i-stargazin fusion protein (black), and GluA4i expressed
alone (blue) or in the presence of stargazin (red). The data represent the
mean 6 S.E.M of recordings from 3–9 oocytes.
doi:10.1371/journal.pone.0049282.g003
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tions were approched, indicative of autoinactivation (Figure 3E).
Again, the fusion protein and coexpressed proteins behaved in an
indistinguishable manner, strongly suggesting that autoinactivation
can occur in the absence of physical dissociation of stargazin -
receptor complex. Based on the initial rising phase of dose-
response curves, both the separately expressed and covalently
linked stargazin caused a similar shift to the left, indicative of an
increased glutamate potency consistent with earlier findings
[10,11,12]. Finally, we examined by immunoprecipitation whether
the noncovalent complex between GluA4i and stargazin is
sensitive to glutamate-induced dissociation. GluA4i and stargazin,
solubilized from transfected HEK293 cells, were immunoprecip-
itated by using an antibody against the N-terminal Flag tag,
present in GluA4i [21] in the presence of 10 mM L-glutamate (a
concentration which causes maximal autoinactivation; cf.
Figure 1D), in the presence of 10 mM D-glutamate, and in the
absence of glutamate. Stargazin immunoprecipitated with GluA4i
to the same extent under all these conditions (Figure S2),
indicating that the physical association of recombinant GluA4i
with stargazin is not significantly affected by the presence of
glutamate under the experimental conditions used.
Discussion
Autoinactivation, the time-dependent uncoupling of stargazin-
dependent augmentation of glutamate responses, was described
and initially characterized in both native and recombinantly
expressed AMPA receptors in a recent study [20]. Our study
confirms the presence of robust autoinactivation in the stargazin-
complexes of homomeric GluA1i, GluA3i and GluA4i channels,
and also shows that, surprisingly, homomeric GluA2 channels
exhibit very little autoinactivation under the same conditions. In
further experiments, the flop isoform of GluA2 showed marked
autoinactivation. Although we examined only the flip isoforms of
non-GluA2 subunits, the earlier study suggested that autoinactiva-
tion is present in GluA1o and GluA2o, and may be weaker in
GluA2i, but the latter finding was not characterized further [20].
However, they used data from two diagnostic glutamate concen-
tration points, rather than a full dose-response curve as determined
in the present study. Flip/flop-isoform-dependent differences in
the modulation of the desensitization kinetics of homomeric
AMPA receptors by stargazin have been previously reported:
generally, the effects on flop-isoform receptors have been stronger
than the effects on the corresponding flip receptors [15,16,22].
Earlier studies have shown that the cytoplasmic tail of stargazin
is crucial for its trafficking role, whereas the extracellular loop
between the first and second transmembrane segments is the
major modulator of receptor function [12,13,23,24]. Presumably,
mutual interactions between these structures and the respectively
located domains of AMPA receptors make critical contributions to
the modulation. This view is supported by the importance of the
extracellular ligand-binding domain of AMPA receptor for the
stargazin modulation [25], and by the essential role of the flip/flop
cassette (part of the ligand-binding domain) in determining the
propensity of GluA2 to undergo stargazin-dependent autoinacti-
vation as reported here. The unique absence of significant
autoinactivation in GluA2i channels prompts future studies to
identify which one(s) of the nine amino acid differences between
the flip and flop variants account for the remarkable difference
between the isoforms. Clearly, the absence of a comparable flip/
flop-difference in GluA1, and possibly in other non-GluA2
subunits, implies that the flip-specific resistance to autoinactivation
is manifested only in the unique structural context of the GluA2
receptor. Interestingly, recent analysis of GluA1/K2 chimeras
showed that the cytosolic carboxylterminal tail of GluA1 is
required for autoinactivation [20], implying that cytosolic elements
and interactions make important contributions to stargazin-
dependent channel modulation, a view supported by another
recent study [26]. Alternatively, the arginine residue in the pore
loop of the edited GluA2 subunit may be important; mutations at
the Q/R site of GluA1 subunit have been reported to exert strong
effects on stargazin-dependent modulation of desensitization [27].
At this stage, it can be concluded that the functional coupling
between stargazin and AMPA receptor is critically dependent on
both extracellular and intracellular interactions. High-resolution
structural information on TARP-receptor complex is eagerly
awaited in order to better resolve this issue.
It is important to note the high macroscopic currents mediated
by homomeric Q/R-edited GluA2 channels when expressed in the
presence of stargazin, an observation reported earlier [10,13]. The
existence of minor populations of native homomeric GluA2
receptors is commonly overlooked in the literature, presumably
based on the weak channel activity of homomeric GluA2(R)
receptors together with reported poor trafficking to cell surface of
homomeric GluA2(R) channels [28]. However, high surface
expression of GluA2(R) homomers has been observed in other
studies (e.g. [27,29], this study) and the presence of active synaptic
GluA2 homomers has been demonstrated, at least under
conditions where the expression of other subunits has been
reduced [30]. Irrespective of the physiological relevance of GluA2
homomers, our finding that the GluA2i subunit may endow
heteromeric GluA1i/A2i receptors with an apparent resistance to
autoinactivation is important. As autoinactivation may act as a
buffering mechanism against excitotoxicity [20], the present results
suggest that GluA2i subunit content of AMPA receptors may be
one of the factors determining the sensitivity of neurons to damage
caused by prolonged exposure to glutamate.
Autoinactivation reflects the uncoupling of stargazin modula-
tion from the receptor channel, but the underlying molecular
mechanism is presently unclear. In principle, the phenomenon
may be caused by physical dissociation of the receptor-stargazin
complex or it may be caused by more subtle structural alterations
which keep the complex intact but lead to loss of the modulatory
effect. There is controversy regarding the stability of stargazin
(TARP) - AMPA receptor complexes. Both the native and
recombinantly expressed complex have been reported to be
readily disrupted by exposure to glutamate [20,23], but in other
studies, rapid agonist-driven dissociation has not been observed
([31], this study). We found that a fusion protein which links the
carboxylterminus of GluA4i to the N-terminus of stargazin shows
strikingly similar autoinactivation to that observed in the case of
separately expressed proteins. This finding, together with stability
of the immunocomplex in the presence of glutamate, argues
against a direct relation between physical dissociation and
autoinactivation. In contrast to our results, covalent linkage
between GluA1o and stargazin was reported to abolish auto-
inactivation [20]. The reason for this discrepancy is not clear, but
differences in the design of the fusion protein remain a possibility.
In particular, the shorter (two amino acid residues) linker used in
GluA1o-stargazin fusion may enforce a more rigid structure to the
complex than the seven-residue linker used in the present study.
Alternatively, the conformational freedom may differ between
GluA1o and GluA4i when covalently linked to stargazin.
Based on research literature and our current results, we envision
the stargazin-AMPA receptor complex to exist in (at least) two
distinct states, designated here as active and passive states,
depending on the presence of TARP modulation of channel
gating (Figure 4). Autoinactivation represents the relaxation of the
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active TARP complex into the passive state in the presence of
glutamate: in GluA2i-containing channels, the active state is
remarkably stable thus inhibiting the autoinactivation process.
This interpretation is consistent with the recent suggestion that
autoinactivation is caused by functional rather than physical
uncoupling [32]. Furthermore, resensitization occurring in AMPA
receptor complexes with TARPs c4, c7, and c8 [1,6] although not
with c2/stargazin, would correspond to the reverse process. The
active and passive states would be in equilibrium with the separate
proteins, but - as judged from robust copurification of TARP with
AMPA receptors from native and recombinant sources [19] - the
equilibrium favours the complex. In addition to GluA2 splice
form, the relative stability of the active and passive TARP
complexes may depend on carboxyl-terminal interactions [20],
may show differences between agonists, and can be regulated by
interactions with additional regulatory proteins like cornichons
[1,33].
Conclusion
Our results show that autoinactivation, the functional uncou-
pling of stargazin modulation of glutamate responses, is a subunit
and splice form-dependent property of AMPA receptors: remark-
ably, homomeric GluA2i and GluA2i-containing heteromeric
receptors show no or very little autoinactivation. Autoinactivation
is not significantly influenced by covalent linkage between
stargazin and AMPA receptor, suggesting that it is caused by
relaxation of stargazin-AMPA receptor complex into a non-
modulated state rather than by physical dissociation.
Materials and Methods
DNA constructs
Expression constructs encoding N-terminal Flag-tagged full-
length rat AMPA receptor cDNAs in pcDNA3.1 (Stratagene) have
been described [29,34]. N-terminally Flag-tagged GluA4i-starga-
zin fusion construct was generated by overlap-extension PCR [35]
using primers which introduced a linker sequence Glu-Leu-Gly-
Thr-Arg-Gly-Ser between the carboxyl-terminal amino acid
residue 902 (Pro) in GluA4 and the aminoterminal methionine
in stargazin coding sequence. The fusion protein construct was
cloned in pXOOM, a dual vector suitable for expression in
mammalian cells and for generation of cRNA by in vitro
transcription with T7 RNA polymerase [36]. GluA4i and
stargazin coding sequences were also separately subcloned from
pcDNA3.1 vector into pXOOM. All new constructs were verified
by restriction mapping and by sequencing through the PCR
amplified regions. The expression plasmid encoding human
stargazin cDNA in pcDNA was a generous gift from John L.
Black III (Mayo Medical School, Rochester, MN). Plasmid
pEGFP-C1 (Clontech).
Cell culture and transfection
HEK293 cells (Americal Type Culture Collection, CRL-1573)
were cultured and transfected as described [34]. For co-expression
studies the plasmids were transfected at a 1:1 ratio using 5–10 mg
DNA per 100-mm culture dish for immunoblotting and immu-
noprecipitation experiments, and 1–2 mg DNA per 35-mm culture
dish for electrophysiology.
Immunoprecipitation
Transfected HEK293 cells were lysed in extraction buffer (1%
Triton X-100, 10 mM Tris-HCl pH7.4, 50 mM NaCl, 1 mM
PMSF, 10 mg/ml leupeptin and aprotinin) for 1 h at 4uC.
Following centrifugation at 13,000 rpm for 15 min at 4uC in a
microfuge, samples were prepared for immunoblotting or the
extracts were subject to immunoprecipitation. For anti-Flag-tag
immunoprecipitation cell extracts were incubated with M2
antibody (Sigma; 1 mg per 500 ml extract) for 60 min at 4uC.
Then, L- or D-glutamate was added to a final concentration of
10 mM, and the incubation was continued for a further 30 min,
followed by harvesting the immunocomplexes with GammaBind
G Sepharose (GE Healthcare).
Immunoblotting
Samples were run on 4–12% SDS-polyacrylamide gradient gels
(Lonza), transferred to PVDF membrane, and blocked in 3% milk
powder/TBS-Tween. Primary antibodies used were: monoclonal
anti-Flag M1 (1 mg/ml; Sigma); rabbit anti-stargazin sera (1:5000;
[21]). Horseradish peroxidase -conjugated anti-mouse IgG
(1:3000) or anti-rabbit IgG (1:3000) (both GE Healthcare) were
used as secondary antibodies. ECL signal was detected by
exposure to HyperfilmTM (GE Healthcare) or by the Bio-Rad
ChemiDoc XRS system and Quantity One software.
Whole cell patch clamp electrophysiology
Whole-cell patch-clamp recordings were made as described
previously [21], except that EPC 9/2 double patch clamp
amplifier and pulse v 8.80 software (HEKA Elektronik, Lam-
brecht, Germany) were used, and the internal solution contained
140 mM CsCl; 2 mM MgCl2; 10 mM EGTA and 10 mM
HEPES (pH adjusted to 7.2 with CsOH and osmolality to
305 mOsm with sucrose). Data was analyzed by using Clampfit
10.2 (Molecular Devices, Sunnyvale, CA) and Prism 3.0 softwares
(GraphPad, San Diego, CA). Each transfection was done at least
twice and 5–8 cells were recorded in each experiment. The data in
graphs are presented as mean 6 SEM. To determine the
rectification index, glutamate-triggered currents were measured
at three different holding potentials (260 mV, 0 mV, +40 mV).
In vitro RNA synthesis and oocyte electrophysiology
All cRNAs were synthesized in vitro by using T7 mMessage
mMachine kit from linearized pXOOM templates according to
manufacturer’s instructions (Ambion, Austin, TX). Xenopus laevis
oocytes of stages V–VI [37] were injected with cRNAs (total of
Figure 4. Active and passive AMPA receptor -TARP complexes.
AMPA receptor (green Y) and TARP (blue trapezoid) are shown in
schematic fashion. The arrows indicate the potential interconversions
between the different states.
doi:10.1371/journal.pone.0049282.g004
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0.4–1 ng in 40 nl per oocyte) by using a Nanoject II injector
(Drummond, Broomall, PA). For coexpression of stargazin and
AMPA receptor subunits, cRNAs were mixed in 1:1 molar ratio.
Oocytes were perfused with 110 mM NaCl, 2 mM KCl, 1 mM
MgCl2, 10 mM HEPES-NaOH, pH 7.4, and standard two-
electrode voltage clamp recordings were performed 1–4 days after
cRNA injection at 270 mV holding potential at 20–22uC using
TURBO TEC-03X amplifier (npi Electronic GmbH, Tamm,
Germany). To analyze inward rectification, currents were
recorded at several intermediate voltage clamp values ranging
from 270 mV to +70 mV. The electrodes were filled with 3 M
KCl and had resistance of 0.8–1.7 MV. Agonists were applied for
30–40 s at flow rate of 2 ml/min. Currents evoked by agonist
perfusion were filtered at 50 Hz and digitized using CellWorks
software (npi electronic).
Supporting Information
Figure S1 Concentration–peak glutamate response
curves for GluA1i/A2i, GluA1i, and GluA2i receptors.
Concentration-response curves for the L-glutamate triggered peak
currents recorded for GluA1i/A2i heteromers, GluA1i homomers
and GluA2i homomers. The figure is assembled from curves
presented in Fig. 1E and and Fig. 2C for easy comparison.
(PDF)
Figure S2 GluA4i and stargazin coimmunoprecipitate in
the presence and absence of glutamate. Triton X-100 -
extract prepared from HEK293 cells coexpressing GluA4i and
stargazin was immunoprecipitated with monoclonal anti-Flag
antibody in the continuous presence of L-glutamate (10 mM), D-
glutamate (10 mM) or in the absence of glutamate as indicated.
Immunocomplexes were resolved in SDS-PAGE and subjected to
western blotting by using anti-stargazin antibody and anti-Flag
antibody for the detection of stargazin (lower panel) and GluA4i
(upper panel), respectively. The experiment was performed four
times with similar results.
(PDF)
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